Stockreport

Acorda Therapeutics craters 24% premarket as FDA rejects Parkinson's application [MarketWatch]

Acorda Therapeutics, Inc.  (ACOR) 
Last acorda therapeutics, inc. earnings: 2/13 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: acorda.com/investors
PDF UPDATE: Acorda Therapeutics shares crater 26% premarket after FDA rejects application for Parkinson's treatment Acorda Therapeutics Inc. shares ACOR, +2.19% slid 26% [Read more]